Effect of pneumococcal conjugate vaccine availability on Streptococcus pneumoniae infections and genetic recombination in Zhejiang, China from 2009 to 2019
Pneumococcal pneumonia is one of the main reasons for child death worldwide. Pneumococcal conjugate vaccines (PCVs) are considered the most effective strategy for pneumococcal disease (PD) prevention, but how a pause in PCV vaccination affects the prevalence of PD or the genetic evolution of Strepto...
Main Authors: | Xueqing Wu, Shanshan Zhao, Yan Jiang, Xi Xiang, Lihong Ge, Qiong Chen, Yanfei Wang, Jorge E. Vidal, Yunsong Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/22221751.2022.2040921 |
Similar Items
-
State-of-the-art in the pneumococcal field: Proceedings of the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11)
by: Brenda Anna Kwambana-Adams, et al.
Published: (2020-02-01) -
Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia
by: Wondewosen Tsegaye Sime, et al.
Published: (2019-05-01) -
Pneumococcal carriage among children under five in Accra, Ghana, five years after the introduction of pneumococcal conjugate vaccine
by: Nicholas T. K. D. Dayie, et al.
Published: (2019-09-01) -
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Severe Invasive Disease Caused by Serotype 3 Streptococcus Pneumoniae in Italian Children
by: Lorenzo Lodi, et al.
Published: (2019-09-01) -
Experience with 13-valent conjugated pneumococcal vaccine in HIV-infected patients
by: A. V. Zhestkov, et al.
Published: (2020-12-01)